TITLE

Abstracts

PUB. DATE
January 1982
SOURCE
Kidney International;Jan1982, Vol. 21 Issue 1, p128
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents abstracts of papers on nephrology. Low renal threshold concentration of phosphate in alcoholic cirrhosis; Effect of parathyroid hormone on energy metabolism of heart; Cimetadine therapy in hypercalcemic hyperparathyroidism of hemodialysis patients.
ACCESSION #
17667487

 

Related Articles

  • Long-term control of parathyroid hormone and calcium-phosphate metabolism after parathyroidectomy in children with chronic kidney disease. Schaefer, Betti; Schlosser, Katja; Wühl, Elke; Schall, Petra; Klaus, Günter; Schaefer, Franz; Schmitt, Claus Peter // Nephrology Dialysis Transplantation;Aug2010, Vol. 25 Issue 8, p2590 

    Background. Hyperparathyroidism (HPT) is an essential contributor to bone disease and cardiovascular calcifications in children with chronic kidney disease (CKD). Pharmacological and dietary interventions are of limited efficacy; calcimimetics are not yet recommended in children....

  • The impact of over-the-counter vitamin D supplements on vitamin D and parathyroid hormone levels in chronic kidney disease. Sekkarie, M. // Clinical Nephrology;2006, Vol. 65 Issue 2, p91 

    Background: In addition to the known disturbances in mineral metabolism and vitamin D activation, the majority of patients with chronic kidney disease (CKD) do not have sufficient vitamin D stores. The impact of supplementation with low-dose, nonactive forms of vitamin D (calciferol) on...

  • The effects of intraperitoneal calcitriol on calcium and parathyroid hormone. Delmez, James A.; Dougan, C. Sue; Gearing, Barbara K.; Rothstein, Marcos; Windus, David W.; Rapp, Neville; Slatopolsky, Eduardo // Kidney International;Mar1987, Vol. 31 Issue 3, p795 

    Parathyroid suppression, by intraperitoneal calcitriol (1,25(OH)2D3) during peritoneal dialysis. The purpose of this study was to determine if parathyroid hormone (PTH) suppression could be achieved by increasing calcium mass transfer (Ca MT) with high dialysate Ca (4 mEq/liter) or via...

  • Small Animal Review. Tennant, Bryn // Companion Animal (2053-0889);2013, Vol. 18 Issue 2, p6 

    The article presents information on increased parathyroid hormone (PTH) production among cats which led to renal disease with adverse metabolic effects including renal secondary hyperparathyroidism. It mentions that elevated PTH in non-azotaemic cats is responsible for maintaining serum...

  • Calcimimetics: A Review of the Recent Literature. Peck, Andrew // Kidney;Jul/Aug2009, Vol. 18 Issue 4, p175 

    Mineral and bone disorders, including secondary hyperparathyroidism, are common in chronic kidney disease and contribute to increased mortality. Traditional therapy to control these disorders involves using phosphate binders and vitamin D sterols, but achieving appropriate results has proved...

  • The Fibroblast Growth Factor 23: A New Player in the Field of Cardiovascular, Bone and Renal Disease. Cozzolino, Mario; Mazzaferro, Sandro // Current Vascular Pharmacology;May2010, Vol. 8 Issue 3, p404 

    Recently, a new view into the molecular mechanisms of phosphate homeostasis and secondary hyperparathyroidism pathogenesis has been proposed, with Fibroblast Growth Factor 23 (FGF-23) as a novel player in the field. Enhanced serum FGF-23 levels cause a reduction in serum phosphate, together with...

  • Marked increase in bone formation markers after cinacalcet treatment by mechanisms distinct from hungry bone syndrome in a haemodialysis patient. Goto, Shunsuke; Fujii, Hideki; Matsui, Yutaka; Fukagawa, Masafumi // Nephrology Dialysis Transplantation;Feb2010, Vol. 3 Issue 1, p71 

    A 59-year-old female who was on dialysis due to diabetic nephropathy was referred to our hospital for severe hyperparathyroidism refractory to intravenous vitamin D receptor activator treatment. With subsequent cinacalcet hydrochloride treatment, parathyroid hormone (PTH) levels were only...

  • Preoperative Serum Osteocalcin may Predict Postoperative Elevated Parathyroid Hormone in Patients with Primary Hyperparathyroidism. Rianon, Nahid; Alex, Gillian; Callender, Glenda; Jimenez, Camilo; Hu, Mimi; Grubbs, Elizabeth; Moreno, Mauricio; Wathoo, Chetna; Petak, Steven; Perrier, Nancy // World Journal of Surgery;Jun2012, Vol. 36 Issue 6, p1320 

    Background: Persistent postoperative elevation of parathyroid hormone (POePTH) following successful parathyroidectomy for primary hyperparathyroidism (PHPT) is presumed to result from bone remineralization. Predicting which patients may need treatment is difficult. This study investigated...

  • RENALNA OSTEODISTROFIJA KOD PACIJENATA NA HEMODIJALIZI. Resić, Halima; Kučukalić-Selimović, Elma; Kapidžić, Adnan; Kukavica, Nihad; Šahović, Vahidin; Mašnić, Fahrudin // Medical Journal;jul-sep2009, Vol. 15 Issue 3, p106 

    Renal osteodistrophy is one of the most common complications of chronic renal failure and one of the risk factors of increased mortality among chronic haemodialysis patients. Aim of the study was to evaluate frequency of renal osteodistrophy in our dialysis population and to identify...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics